Brain PET in the Diagnosis of Alzheimer’s Disease
Year: 2014
Type: review
Abstract: OBJECTIVES: The aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET can help in differentiating Alzheimer's disease from other causes of dementia such as frontotemporal dementia and dementia of Lewy body. Amyloid brain PET may exclude significant amyloid deposition and thus Alzheimer's disease in appropriate clinical setting. CONCLUSIONS: FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.
Source: Clinical Nuclear Medicine
Institutions: Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2317490759
